267 related articles for article (PubMed ID: 11876749)
1. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
[TBL] [Abstract][Full Text] [Related]
2. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
3. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
[TBL] [Abstract][Full Text] [Related]
4. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
5. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
6. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis.
Fujisawa T; Fujisawa R; Kato Y; Nakayama T; Morita A; Katsumata H; Nishimori H; Iguchi K; Kamiya H; Gray PW; Chantry D; Suzuki R; Yoshie O
J Allergy Clin Immunol; 2002 Jul; 110(1):139-46. PubMed ID: 12110833
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.
Horikawa T; Nakayama T; Hikita I; Yamada H; Fujisawa R; Bito T; Harada S; Fukunaga A; Chantry D; Gray PW; Morita A; Suzuki R; Tezuka T; Ichihashi M; Yoshie O
Int Immunol; 2002 Jul; 14(7):767-73. PubMed ID: 12096036
[TBL] [Abstract][Full Text] [Related]
8. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
9. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children.
Leung TF; Ma KC; Hon KL; Lam CW; Wan H; Li CY; Chan IH
Pediatr Allergy Immunol; 2003 Aug; 14(4):296-301. PubMed ID: 12911508
[TBL] [Abstract][Full Text] [Related]
11. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
12. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
Hashimoto S; Nakamura K; Oyama N; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
[TBL] [Abstract][Full Text] [Related]
15. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
17. TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients.
Lin L; Nonoyama S; Oshiba A; Kabasawa Y; Mizutani S
J Med Dent Sci; 2003 Mar; 50(1):27-33. PubMed ID: 12715916
[TBL] [Abstract][Full Text] [Related]
18. Levels of immunoglobulin E specific to the major food allergen and chemokine (C-C motif) ligand (CCL)17/thymus and activation regulated chemokine and CCL22/macrophage-derived chemokine in infantile atopic dermatitis on Ishigaki Island.
Esaki H; Takeuchi S; Furusyo N; Yamamura K; Hayashida S; Tsuji G; Takemura M; Hayashi J; Furue M
J Dermatol; 2016 Nov; 43(11):1278-1282. PubMed ID: 27028543
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
20. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
